Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
Public ClinicalTrials.gov record NCT03198286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Study identification
- NCT ID
- NCT03198286
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Other
- Enrollment
- 40 participants
Conditions and interventions
Conditions
- Stage I Breast Cancer
- Stage I Cervical Cancer
- Stage I Ovarian Cancer
- Stage I Uterine Corpus Cancer
- Stage IA Breast Cancer
- Stage IA Cervical Cancer
- Stage IA Ovarian Cancer
- Stage IA Uterine Corpus Cancer
- Stage IB Breast Cancer
- Stage IB Cervical Cancer
- Stage IB Ovarian Cancer
- Stage IB Uterine Corpus Cancer
- Stage IC Ovarian Cancer
- Stage II Breast Cancer
- Stage II Cervical Cancer
- Stage II Ovarian Cancer
- Stage II Uterine Corpus Cancer
- Stage IIA Breast Cancer
- Stage IIA Cervical Cancer
- Stage IIA Ovarian Cancer
- Stage IIB Breast Cancer
- Stage IIB Cervical Cancer
- Stage IIB Ovarian Cancer
- Stage IIC Ovarian Cancer
- Stage III Breast Cancer
- Stage III Cervical Cancer
- Stage III Ovarian Cancer
- Stage III Uterine Corpus Cancer
- Stage IIIA Breast Cancer
- Stage IIIA Cervical Cancer
- Stage IIIA Ovarian Cancer
- Stage IIIA Uterine Corpus Cancer
- Stage IIIB Breast Cancer
- Stage IIIB Cervical Cancer
- Stage IIIB Ovarian Cancer
- Stage IIIB Uterine Corpus Cancer
- Stage IIIC Breast Cancer
- Stage IIIC Ovarian Cancer
- Stage IIIC Uterine Corpus Cancer
Interventions
- Informational Intervention Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2015
- Primary completion
- Jul 31, 2015
- Completion
- Oct 30, 2016
- Last update posted
- Apr 28, 2025
2015 – 2016
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sidney Kimmel Cancer Center at Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Reading Hospital | Reading | Pennsylvania | 19602 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03198286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03198286 live on ClinicalTrials.gov.